Philips Coronary artery disease solutions

Coronary artery disease

Transforming complex PCI procedures into confident care

    As the prevalence of coronary artery disease (CAD) grows globally, interventional cardiologists are feeling the strain. With an ever-increasing case load and a squeeze on resources, delivering efficient, cost-effective and high-quality care presents significant challenges. At Philips, we also recognize that the cath lab is a complex landscape, made up of different information and systems. Philips offers a fully integrated ecosystem designed to meet today’s challenges and can provide you with more information faster. This enhances cath lab performance and which ultimately can support confident decisions and exceptional patient care. Moreover, our smart management of X-ray dosage is there to enhance patient care.

    Coronary image

    Coronary suite - Boost performance today, to exceed expectations in the future

    Improving lab performance while focusing on the patient

    Philips coronary suite has advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, all working together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance  and efficiency today, while serving as your launching pad to the future:

    Imagine if you could aggregate system performance data to improve departmental performance. Imagine if you could aggregate all patient cardio data to improve procedural decision making.

    Philips is your partner of choice when it comes to coronary interventions

    Convenient, one-stop-shop to easily access solutions for coronary interventions, with a focus on physiology and imaging applications, to support lab performance.

    Solutions for every step of coronary procedures, from diagnosis to restoring vessel patency.

    A scalable platform for a roadmap to the future, designed to accommodate new technology.

    When you invest in Philips coronary suite, you are investing in a path to future technological advancements and capabilities. As we move from a mainly transactional to a value-based pathway in healthcare, integration, usability and artificial intelligence will drive the industry forward. It’s exciting to think of what’s possible when care providers can access the tools and technologies they need to create a fully integrated and transformed interventional cardiology service.

    Explore what Philips image guided therapy has to offer for PCI

    • Percutaneous coronary intervention

      Percutaneous coronary intervention

      Solutions for coronary artery disease for PCI procedures offered by Philips image-guided therapy.

      Click here to learn more

    Key products of coronary suite

    Azurion system

    Azurion

    Experience the new world of interventional cardiac and vascular performance with the Azurion 7 series with 12'' flat detector.

    IntraSight image

    IntraSight

    The IntraSight applications platform is where imaging, physiology, co-registration1 and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans.

    iFR clinical outcomes

    iFR modality

    iFR is the gold standard among resting indices backed by patient outcomes that reduces costs, procedural time and patient discomfort2-4 while providing advance guidance with co-registration.

    Integrated cardiology solutions

    Dynamic Coronary Roadmap

    Automatic, real-time navigational guidance designed for procedure efficiency in complex PCI interventions without changing current standard workflow.

    Purposeful innovation. Empowered care.

     

    Our CAD solutions work together to help you provide quick, confident diagnosis, along with effective, efficient treatment – ultimately contributing to improved outcomes.

    References

    1 Co-registration tools available within IntraSight 7 configuration via SyncVision.

    2 Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decisionmaking.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

    3 Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017;376:1813-1823
    4 Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376: 1824-1834.

    We are always interested in engaging with you.

    Let us know how we can help.

    1
    Select your area of interest
    2
    Contact details

    You are about to visit a Philips global content page

    Continue

    You are about to visit a Philips global content page

    Continue

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

    Ön belépni kíván a magyar Philips Healthcare weboldalára.
    Please select the checkbox

    Ez a weboldal kizárólag olyan személyek számára készült, akik mint szakemberek használják az orvostechnikai eszközöket, ideértve az orvosi szakmát gyakorló személyeket, az egészségügyi intézmények képviseletében eljáró magánszemélyeket vagy az orvostechnikai eszközöket szakmai célból vásárlókat.

    Ön olyan személy, aki megfelel a fenti kritériumoknak?